Literature DB >> 12223315

The promiscuous MLL gene links chromosomal translocations to cellular differentiation and tumour tropism.

Emma C Collins1, Terence H Rabbitts.   

Abstract

MLL is a promiscuous gene involved in a diversity of chromosomal fusions in haematological malignancies, usually resulting from chromosomal translocations. MLL-associated chromosomal rearrangements usually occur in tumours of specific haematological lineages, suggesting a crucial role for the MLL fusion partner in determining disease phenotype (or tumour tropism). The MLL gene is homologous to Drosophila trithorax, and is likewise involved in embryo pattern formation. Common themes linking several of the MLL partners include a possible involvement in embryo patterning via Hox gene regulation and chromatin remodelling. These findings reinforce the link between developmental regulation and chromosomal translocations, and indicate the role of chromosomal translocation in activating genes capable of determining tumour phenotype in leukaemias and sarcomas.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12223315     DOI: 10.1016/s1471-4914(02)02397-3

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  19 in total

1.  Histone 3 lysine 4 methylation during the pre-B to immature B-cell transition.

Authors:  Eric J Perkins; Barbara L Kee; Dale A Ramsden
Journal:  Nucleic Acids Res       Date:  2004-03-29       Impact factor: 16.971

2.  Human AML-iPSCs Reacquire Leukemic Properties after Differentiation and Model Clonal Variation of Disease.

Authors:  Mark P Chao; Andrew J Gentles; Susmita Chatterjee; Feng Lan; Andreas Reinisch; M Ryan Corces; Seethu Xavy; Jinfeng Shen; Daniel Haag; Soham Chanda; Rahul Sinha; Rachel M Morganti; Toshinobu Nishimura; Mohamed Ameen; Haodi Wu; Marius Wernig; Joseph C Wu; Ravindra Majeti
Journal:  Cell Stem Cell       Date:  2017-01-12       Impact factor: 24.633

3.  Zinc Finger Nuclease induced DNA double stranded breaks and rearrangements in MLL.

Authors:  To Uyen Do; Bay Ho; Shyh-Jen Shih; Andrew Vaughan
Journal:  Mutat Res       Date:  2013-01-02       Impact factor: 2.433

Review 4.  Molecular pathogenesis of MLL-associated leukemias.

Authors:  Mariko Eguchi; Minenori Eguchi-Ishimae; Mel Greaves
Journal:  Int J Hematol       Date:  2005-07       Impact factor: 2.490

5.  Mouse Af9 is a controller of embryo patterning, like Mll, whose human homologue fuses with Af9 after chromosomal translocation in leukemia.

Authors:  Emma C Collins; Alexandre Appert; Linda Ariza-McNaughton; Richard Pannell; Yoshihiro Yamada; Terence H Rabbitts
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

6.  MLL rearrangements in pediatric acute lymphoblastic and myeloblastic leukemias: MLL specific and lineage specific signatures.

Authors:  Andrea Zangrando; Marta Campo Dell'orto; Geertruy Te Kronnie; Giuseppe Basso
Journal:  BMC Med Genomics       Date:  2009-06-23       Impact factor: 3.063

7.  Intrinsic structural disorder confers cellular viability on oncogenic fusion proteins.

Authors:  Hedi Hegyi; László Buday; Peter Tompa
Journal:  PLoS Comput Biol       Date:  2009-10-30       Impact factor: 4.475

8.  Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression.

Authors:  Akihiko Yokoyama; Zhong Wang; Joanna Wysocka; Mrinmoy Sanyal; Deborah J Aufiero; Issay Kitabayashi; Winship Herr; Michael L Cleary
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

9.  The histone methyltransferase KMT2B is required for RNA polymerase II association and protection from DNA methylation at the MagohB CpG island promoter.

Authors:  Vasileios Ladopoulos; Helmut Hofemeister; Maarten Hoogenkamp; Arthur D Riggs; A Francis Stewart; Constanze Bonifer
Journal:  Mol Cell Biol       Date:  2013-01-28       Impact factor: 4.272

Review 10.  Translocations in epithelial cancers.

Authors:  J Chad Brenner; Arul M Chinnaiyan
Journal:  Biochim Biophys Acta       Date:  2009-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.